Search

Your search keyword '"Mayerle, Julia"' showing total 1,638 results

Search Constraints

Start Over You searched for: Author "Mayerle, Julia" Remove constraint Author: "Mayerle, Julia"
1,638 results on '"Mayerle, Julia"'

Search Results

1. Characterization of cognitive symptoms in post COVID-19 patients

2. Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?

6. Intensivtherapie bei akuter Pankreatitis

7. Electronic data capture in resource-limited settings using the lightweight clinical data acquisition and recording system

12. Substantial differences in perception of disease severity between post COVID-19 patients, internists, and psychiatrists or psychologists: the Health Perception Gap and its clinical implications

15. A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich

17. Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response

18. Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events

19. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment

21. Investigation of the Interplay between Circulating Lipids and IGF-I and Relevance to Breast Cancer Risk: An Observational and Mendelian Randomization Study

22. The impact of physiological stress conditions on protein structure and trypsin inhibition of serine protease inhibitor Kazal type 1 (SPINK1) and its N34S variant

23. Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board

24. Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based study

25. An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets

26. Intensivtherapie bei akuter Pankreatitis

30. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment

31. CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liver

32. Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning

33. Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis

34. Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis—Knowledge Gaps and Research Opportunities

36. HLA-DRB1∗16 and -DQB1∗05 alleles are strongly associated with autoimmune pancreatitis in a cohort of hundred patients

40. Early infection is an independent risk factor for increased mortality in patients with culture-confirmed infected pancreatic necrosis

41. Severity of Gallstone-, Sludge-, or Microlithiasis-Induced Pancreatitis--All of the Same?

46. Sequential or up-front triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma (HCC): MONTBLANC.

47. Abstract A055: Context-dependent role of acid sphingomyelinase in pancreatic ductal adenocarcinoma

48. Altered histone acetylation patterns in pancreatic cancer cell lines induce subtype‑specific transcriptomic and phenotypical changes

49. The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4-/- Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology

50. Metabolic Biomarkers of Pancreatic Cancer

Catalog

Books, media, physical & digital resources